AI Article Synopsis
- - Cefiderocol is a new type of antibiotic designed to treat severe infections caused by multidrug-resistant bacteria, such as sepsis and certain types of pneumonia in adults.
- - Its use in newborns is limited, with only a few documented cases so far.
- - The text highlights a successful treatment case where cefiderocol was used to treat a newborn with pneumonia-related sepsis caused by the bacteria Stenotrophomonas maltophilia.
Article Abstract
Cefiderocol is a new siderophore-beta-lactam antibiotic used for the treatment of severe multidrug-resistant infections like sepsis, hospital-acquired and ventilator-associated pneumonia in adults, but there are only single reports on its use in the neonatal population. We describe the successful cefiderocol treatment of a newborn with pneumogenic sepsis due to Stenotrophomonas maltophilia.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s15010-024-02404-9 | DOI Listing |
Publication Analysis
Top Keywords
stenotrophomonas maltophilia
8
successful therapy
4
therapy newborn
4
newborn stenotrophomonas
4
maltophilia nosocomial
4
nosocomial pneumonia
4
pneumonia cefiderocol
4
cefiderocol cefiderocol
4
cefiderocol siderophore-beta-lactam
4
siderophore-beta-lactam antibiotic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!